Loading stock data...

Norris Medicines Limited

BSE: NORRIS

BSE
16.77 0.71 (4.42%)

Prev Close

16.06

Open Price

16.5

Volume

916

Today Low / High

16.46 / 16.86

52 WK Low / High

14.78 / 24.16

Range

16 - 18

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 16.77, reflecting a change of 0.71 (4.42092%). The expected target range on the BSE is 16 - 18. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

01 Oct 16.50 1.64%
30 Sep 16.50 -2.67%
29 Sep 15.81 4.87%
26 Sep 16.98 -2.24%
25 Sep 16.75 -0.60%
24 Sep 16.61 -3.55%
23 Sep 17.25 -3.54%
22 Sep 17.95 -8.41%
19 Sep 16.17 6.62%
18 Sep 16.60 -0.60%
17 Sep 17.45 -4.87%
16 Sep 16.86 3.38%
15 Sep 17.50 -3.66%
12 Sep 17.31 -1.96%
11 Sep 17.47 -2.86%
10 Sep 16.06 4.86%
09 Sep 16.03 0.12%
08 Sep 16.99 -5.77%
05 Sep 16.31 -0.37%
04 Sep 16.92 -3.61%

Norris Medicines Limited Graph

Norris Medicines Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Norris Medicines Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 16.77, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 16.77 16.94 15.24 - 18.63
17.11 13.68 - 20.53
17.27 12.09 - 22.46
Bearish Scenario 16.77 16.60 14.94 - 18.26
16.43 13.15 - 19.72
16.27 11.39 - 21.15

Overview of Norris Medicines Limited

ISIN

INE744C01029

Industry

Medical - Pharmaceuticals

Vol.Avg

1,027

Market Cap

167,711,739

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

33.20

DCF

-16

Financial Ratios Every Investor Needs

Stock Rating Details for NORRIS

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 1 Strong Sell
ROE Score 4 Buy
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 5.82 Cr 3.51 Cr 2.31 Cr 0.3972 0.00 Cr 1.41 Cr 0.90 Cr -1.24 Cr -1.24 -0.22 Cr -0.2126
2024-03-31 5.64 Cr 2.70 Cr 2.94 Cr 0.5210 0.00 Cr 0.00 Cr 1.12 Cr -1.19 Cr -1.19 -0.18 Cr -0.2106
2023-03-31 8.36 Cr 3.52 Cr 4.84 Cr 0.5785 0.00 Cr 2.30 Cr 2.54 Cr -1.75 Cr -1.75 0.93 Cr -0.2093
2022-03-31 9.44 Cr 5.73 Cr 3.71 Cr 0.3934 0.00 Cr 2.33 Cr -0.72 Cr -3.26 Cr -3.26 -0.06 Cr -0.3458
2021-03-31 12.25 Cr 8.91 Cr 3.34 Cr 0.2729 0.00 Cr 0.00 Cr 0.24 Cr -4.96 Cr -4.96 -1.74 Cr -0.4050

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.04 Cr 13.81 Cr 28.68 Cr -14.8675 Cr 21.58 Cr 21.54 Cr 4.13 Cr 5.27 Cr 0.00 Cr 0.00 Cr 0.01 Cr 10.1500 Cr
2024-03-31 0.04 Cr 14.19 Cr 27.82 Cr -13.6300 Cr 21.52 Cr 21.49 Cr 4.33 Cr 5.79 Cr 0.00 Cr 0.00 Cr 0.01 Cr 9.2256 Cr
2023-03-31 0.02 Cr 13.69 Cr 26.13 Cr -12.4433 Cr 21.40 Cr 21.38 Cr 3.20 Cr 6.47 Cr 0.00 Cr 0.00 Cr 0.01 Cr 7.7046 Cr
2022-03-31 0.02 Cr 14.19 Cr 24.88 Cr -10.6938 Cr 21.08 Cr 21.06 Cr 2.43 Cr 7.07 Cr 0.00 Cr 0.00 Cr 0.01 Cr 6.7837 Cr
2021-03-31 0.02 Cr 19.79 Cr 27.22 Cr -7.4303 Cr 18.39 Cr 18.36 Cr 5.32 Cr 7.67 Cr 0.00 Cr 0.00 Cr 0.01 Cr 11.6940 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.5101 Cr -0.0039 Cr -0.5039 Cr 0.4910 Cr 0.0022 Cr 0.0398 Cr -0.0190 Cr -1.2375 Cr -0.0644 Cr 0.0000 Cr 0.2054 Cr
2024-03-31 0.1698 Cr 0.0507 Cr -0.2033 Cr 0.1686 Cr 0.0172 Cr 0.0376 Cr -0.0011 Cr -1.1868 Cr 0.1665 Cr 0.0000 Cr -1.1351 Cr
2023-03-31 1.1995 Cr -0.0218 Cr -1.1760 Cr 1.1697 Cr 0.0017 Cr 0.0203 Cr -0.0299 Cr -1.7495 Cr 0.3243 Cr 0.0000 Cr -0.7776 Cr
2022-03-31 -1.0094 Cr -0.0889 Cr 1.0963 Cr -1.0648 Cr -0.0021 Cr 0.0186 Cr -0.0554 Cr -3.2635 Cr 2.5778 Cr 0.0000 Cr 2.6815 Cr
2021-03-31 1.1136 Cr -0.0619 Cr -1.0945 Cr 1.0256 Cr -0.0428 Cr 0.0207 Cr -0.0880 Cr -4.9619 Cr 0.5400 Cr 0.0000 Cr -1.0968 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 1.46 Cr 0.73 Cr 0.73 Cr 0.5022 0.32 Cr -0.31 Cr -0.31 -0.09 Cr -0.2131
2025-03-31 2.72 Cr 1.82 Cr 0.90 Cr 0.3307 0.38 Cr -0.23 Cr -0.23 0.11 Cr -0.0840
2024-12-31 1.11 Cr 0.59 Cr 0.52 Cr 0.4702 0.26 Cr -0.28 Cr -0.28 -0.02 Cr -0.2547
2024-09-30 1.27 Cr 0.93 Cr 0.34 Cr 0.2679 0.05 Cr -0.36 Cr -0.36 -0.15 Cr -0.2847
2024-06-30 0.72 Cr 0.17 Cr 0.55 Cr 0.7619 0.21 Cr -0.37 Cr -0.37 -0.15 Cr -0.5052

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 14.87 Cr
2025-03-31 0.04 Cr 0.00 Cr 0.04 Cr 1.41 Cr 4.13 Cr 6.34 Cr 5.27 Cr 13.81 Cr 28.68 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 14.36 Cr
2024-09-30 0.02 Cr 0.00 Cr 0.02 Cr 0.79 Cr 3.88 Cr 5.23 Cr 5.54 Cr 12.98 Cr 27.34 Cr
2024-06-30 -0.04 Cr 0.08 Cr 0.04 Cr 0.00 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr 13.63 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 -0.31 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -0.23 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -0.28 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -0.37 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹741.10 ₹88,742,053,847.00 ₹95,115.00

Key Executives

Chief Financial Officer
Mr. Iqubal Ismail Patel

Gender: male

Year Born: 1963

General Manager of Marketing
Manish Seth

Gender: Not Specified

Year Born: 1970

General Manager of Operations
Bharat B. Shah

Gender: Not Specified

Year Born: 1956

Company Secretary & Compliance Officer
Ms. Priyanka Lohiya

Gender: female

Year Born:

MD & Executive Director
Mr. Vimal Dhirendra Shah

Gender: male

Year Born: 1976

FAQs about Norris Medicines Limited

Who is the CEO of the company?

The CEO is Vimal Dhirendra Shah.

What is the current market price of the stock?

The current price is ₹16.77.

What is the 52-week price range?

The range is ₹14.78-24.16.

What is the market capitalization of the company?

The market capitalization is ₹16.77 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -14.21.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Norris Medicines Limited (ISIN: INE744C01029) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹16.77 crores and an average daily volume of 1,027 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.